Vetviva Richter Gmbh

What Vetviva Richter Gmbh does

VetViva Richter GmbH is an Austrian veterinary pharmaceutical manufacturer headquartered at Durisolstraße 14, Wels, Austria. Founded in 2023 as a 100% subsidiary of Richter Pharma AG, the company develops, manufactures, and distributes "generic+" veterinary medicinal products — generic-equivalent medications combined with additional therapeutic benefits — across more than 700 medicinal product authorizations and serving over 50 countries worldwide. It holds GMP certification for its pharmaceutical production and focuses on analgesics and anaesthetics (pain treatment) for large animals, small animals, and horses. Core products include Dogstem, Benadil (antihistamine tablets for dogs and cats), Pergoquin (for horses), Caniphedrin and Vitofyllin (for dogs), with packaging variants distributed across Austria, Bulgaria, Romania, and Slovakia.

The company operates a sales-led go-to-market model, combining direct sales to veterinarians with a multi-jurisdictional distribution-partner network anchored by regional subsidiaries in Bulgaria (VetViva Bulgaria EOOD) and Romania (VetViva Richter SRL). It supports partners through a dedicated Vetviva4Partners portal providing marketing materials and scientific information, plus VetViva Forecast Pro and VetViva Stem Pro as demand-forecasting and ordering tools. Pricing is not publicly disclosed; customers contact the sales team for product-level pricing. The business is wholly-owned by Richter Pharma AG, with strategic oversight and operational integration handled at the parent level. In October 2025, VetViva inaugurated a EUR 35 million production facility in Wels dedicated to pain-treatment veterinary pharmaceuticals, representing the company's most significant capital commitment to date.

Revenue mechanics rely on one-time product sales of veterinary medicinal products and feed supplements distributed through enterprise-tier customers (veterinarians, veterinary practices, and long-standing distribution partners). The GTM motion emphasizes close cooperation with veterinarians and long-standing distributors across international markets, supported by training programs, conference participation (London VetShow, VIV MEA Abu Dhabi, national/international congresses), and a customer-centric commercial approach organized around four guiding principles: Customer Centricity, Creating Products, Creating Competence, and Creating Business.

Name

Vetviva Richter Gmbh

Legal name

VetViva Richter GmbH

Website

https://vetviva.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

VetViva Richter GmbH is an Austrian veterinary pharmaceutical manufacturer, founded in 2023 as a subsidiary of Richter Pharma AG, developing and distributing "generic+" veterinary medicines across 50+ countries with 700+ product authorizations, focused on analgesics and pain treatment.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)

akta.pro secondary industries

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Veterinary analgesics
• Veterinary feed supplements
• Veterinary medicines

Headquarters

HQ city

Wels

HQ country

Austria

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Infrastructure, Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Veterinary Medicinal Product Sales: Development, manufacture, and distribution of medicinal products and feed supplements for the veterinary sector. The company holds over 700 medicinal product authorizations and exports to more than 50 countries worldwide.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

VetViva Richter GmbH develops, manufactures, and distributes veterinary medicinal products and feed supplements under a "generic+" approach, with a core focus on analgesics and anaesthetics for pain treatment across large animals, small animals, and horses. The company holds over 700 medicinal product authorizations, produces at GMP-certified facilities including a new 35 million EUR plant in Wels, Austria, and exports to more than 50 countries through direct veterinarian engagement and an international distribution partner network.

Product overview

VetViva Richter GmbH offers a portfolio of veterinary medicinal products primarily consisting of 'generic+' products - generic veterinary medications with additional benefits beyond pure generics. The product portfolio includes medications for large animals, small animals, and horses. Key products include Benadil (antihistamine for dogs and cats), Pergoquin (for horses), Caniphedrin and Vitofyllin (for dogs), and specialized products like Dogstem. The company operates GMP-certified manufacturing facilities with a focus on pain treatment and holds over 700 medicinal product authorizations.

Differentiator

Problem solved

Functional benefit

Brands

• Dogstem: Veterinary product brand for dogs
• Vetviva4Partners
• VetViva Forecast Pro
• VetViva Stem Pro

Products and services

• Dogstem Specialized veterinary product for dogs, featured in VetViva's product portfolio.
• Benadil Veterinary antihistamine product available in 5mg film-coated tablets (for dogs and cats) and 20mg film-coated tablets (for dogs).
• Pergoquin Veterinary product in 1mg tablet form for horses.
• Caniphedrin Veterinary product available in 20mg and 50mg tablet formulations for dogs.
• Vitofyllin Veterinary product available in 50mg and 100mg film-coated tablet formulations for dogs.

Quantifiable outcome

• Products exported to over 50 countries worldwide

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Richter Pharma AGcoreStrategic or Co-development PartnerVetViva Richter GmbH was founded in 2023 as a 100% subsidiary of Richter Pharma AG. Richter Pharma AG is the parent company providing strategic oversight and integration within the Austrian pharmaceutical group.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Virbac: France-based dedicated animal health company offering pharmaceuticals, vaccines, and other products across companion and livestock segments; overlaps with VetViva in veterinary drug manufacturing and export-driven distribution.
• Ceva Santé Animale: Global veterinary pharmaceutical group with strong generics and specialty portfolio, headquartered in France; directly comparable to VetViva in pharmaceutical manufacturing, multi-species coverage, and international distribution model.
• Vetoquinol: Independent French veterinary pharmaceutical company offering a broad portfolio of generics and specialty medicines across companion and production animals; comparable to VetViva in business model, species coverage, and channel mix.
• Bimeda Animal Health: Privately held global veterinary pharmaceutical company producing generics and specialty products across livestock and companion animals; comparable in size profile, generics focus, and global distribution.
• Chanelle Pharmaceuticals: Irish veterinary pharmaceutical manufacturer with a large generics portfolio and strong international distribution; closely comparable to VetViva in generic drug manufacturing and export-led growth.
• Dechra Pharmaceuticals: UK-headquartered specialist veterinary pharmaceuticals company focused on companion animal generics and specialty therapeutics; directly comparable in generic+ positioning and species-segment focus.

Broad incumbents

• Elanco Animal Health: Major animal health incumbent formed from Eli Lilly's animal health unit plus Bayer Animal Health; competes across the same veterinary pharmaceutical categories as VetViva but at much greater scale.
• MSD Animal Health (Merck Animal Health): Animal health division of Merck; a broad incumbent offering pharmaceuticals, vaccines, and biologics across all major species, overlapping with VetViva's therapeutic categories.
• Phibro Animal Health: Diversified animal health and mineral nutrition company with a meaningful generics and specialty pharma portfolio; comparable in livestock-heavy veterinary pharmaceutical manufacturing.
• Zoetis: Largest dedicated animal health company globally; competes broadly with VetViva across pharmaceuticals, vaccines and diagnostics, with deeper R&D and direct sales infrastructure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vetviva-richter-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vetviva Richter Gmbh